Cerus Corporation (CERS)
Makes technology that removes deadly germs from donated blood before transfusion.
$2.92-0.05%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+129.9%
The outlook
CERS trades at $2.92, well above its 50- and 200-day moving averages and positioned three-quarters of the way up its 52-week range. Analyst coverage shows an average price target roughly 60% above the current level, while the overall sentiment leans bullish based on available data.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range76% of the way from its 52-week low to high
Price targetAvg target +60% vs current price
Analyst price target
~12-month · 3 analysts$4.67average target+59.8% vs now
Now $2.92
Low $4.00High $5.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$585.1M
52-wk high
$3.47
52-wk low
$1.15
50-day avg
$2.84
200-day avg
$2.21
Trailing P/E
—